Skip to main content

Ashton Thomas Securities, LLC

SEC CIK
0000771572
Latest filing
Jul 27, 2026

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by Ashton Thomas Securities, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings

Shares (Q2 2026)
3,091
Value
$1.53M
% of portfolio
0.2%
Quarters held
9
Since Q2 2024
Holdings of VRTX by Ashton Thomas Securities, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20263,091$1.53M0.2%+43+1.4%AddedHolders
Q1 20263,048$1.36M0.2%+146+5.0%AddedHolders
Q4 20252,902$1.32M0.2%−79−2.7%ReducedHolders
Q3 20252,981$1.17M0.2%−710−19.2%ReducedHolders
Q2 20253,691$1.64M0.4%+12+0.3%AddedHolders
Q1 20253,679$1.78M0.5%+435+13.4%AddedHolders
Q4 20243,244$1.31M0.4%+55+1.7%AddedHolders
Q3 20243,189$1.48M0.3%+188+6.3%AddedHolders
Q2 20243,001$1.46M0.4%–No prior filingHolders